Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Surbhi Khanna

Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil

Shares of Biocon rose 2% on Tuesday, hitting the day’s high of Rs 399 on NSE after the company secured a 10-year supply contract for Pertuzumab in Brazil for breast cancer therapy.

According to a filing with the exchange, the company said it signed a partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil, marking an important milestone in advancing production and commercialisation of the HER2-positive breast cancer therapy under the country’s Productive Development Partnership (PDP) program.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.